Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Interim results from the defifrance study

被引：0

作者：

Mohty, Mohamad ^{[1
]}

Labopin, Myriam ^{[1
]}

Lebon, Delphine ^{[2
]}

Berceanu, Ana ^{[3
]}

Jubert, Charlotte ^{[4
]}

Yakoub-Agha, Ibrahim ^{[5
]}

Girault, Stephane ^{[6
]}

Detrait, Marie ^{[7
]}

Pochon, Cecile ^{[8
]}

Rialland, Fanny ^{[9
]}

Gandemer, Virginie ^{[10
]}

de Latour, Regis Peffault ^{[11
]}

Michonneau, David ^{[11
]}

Delaval, Floriane ^{[12
]}

Michel, Gerard ^{[13
]}

Sirvent, Anne ^{[14
]}

Clement, Laurence ^{[15
]}

Menard, Anne-Lise ^{[16
]}

Huynh, Anne ^{[17
]}

Bouvatier, Virginie ^{[18
]}

Hanvesakul, Raj ^{[19
]}

Medeghri, Zakaria ^{[18
]}

Dalle, Jean-Hugues ^{[20
]}

机构：

[1] Hop St Antoine, Paris, France

[2] Chu Amiens Picardie Hop, Amiens, France

[3] Hop Jean Minjoz, Besancon, France

[4] Hop Enfants, Bordeaux, France

[5] Hop Claude Huriez, Lille, France

[6] CHU Limoges, Hop Dupuytren, Limoges, France

[7] CHU Nancy, Nancy, France

[8] Hop Enfants, Nancy, France

[9] Hop Hotel Dieu, Nantes, France

[10] CHU Hop Sud, Rennes, France

[11] Hop St Louis, Paris, France

[12] Jazz Pharmaceut, Paris, France

[13] Hop la Timone, Marseille, France

[14] Hop Arnaud de Villeneuve, Montpellier, France

[15] Hop Haut Leveque, Pessac, France

[16] Ctr Henri Becquerel, Rouen, France

[17] IUCT Oncopole, Toulouse, France

[18] Jazz Pharmaceut, Lyon, France

[19] Jazz Pharmaceut, Oxford, England

[20] Hop Robert Debre, Paris, France

来源：

BONE MARROW TRANSPLANTATION | 2019年 / 54卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P136

引用

页码：231 / 232

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF DEFIBROTIDE IN THE TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL SUBGROUP RESULTS
Richardson, P.
Smith, A.
Triplett, B.
Kernan, N.
Grupp, S.
Antin, J.
Lehmann, L.
Giralt, S.
Liang, W.
Hume, R.
Tappe, W.
Soiffer, R.
HAEMATOLOGICA, 2017, 102 : 303 - 303
[2] Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
Mohty, Mohamad
Yakoub-Agha, Ibrahim
Labopin, Myriam
Blaise, Didier
Lebon, Delphine
Gandemer, Virginie
Maury, Sebastien
Renard, Cecile
Jubert, Charlotte
Ryan, Robert J.
Bouvatier, Virginie
Dalle, Jean-Hugues
De latour, Regis Peffault
BLOOD, 2020, 136
[3] Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study
Richardson, Paul G.
Smith, Angela R.
Triplett, Brandon M.
Kernan, Nancy A.
Grupp, Stephan A.
Antin, Joseph H.
Lehmann, Leslie
Shore, Tsiporah
Iacobelli, Massimo
Miloslaysky, Maja
Hume, Robin
Hannah, Alison L.
Nejadnik, Bijan
Soiffer, Robert J.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (06) : 997 - 1004
[4] Pooled safety analysis of defibrotide treatment in patients with HEPATIC veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) following hematopoietic stem cell transplantation (HSCT)
Richardson, Paul
Smith, Angela
Kernan, Nancy
Lehmann, Leslie
Ryan, Robert
Tappe, William
Grupp, Stephan
BONE MARROW TRANSPLANTATION, 2019, 54 : 229 - 230
[5] EFFICACY AND SAFETY OF DEFIBROTIDE IN THE TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) FOLLOWING CHEMOTHERAPY
Kernan, Nancy A.
Richardson, Paul G.
Triplett, Brandon M.
Grupp, Stephan A.
Antin, Joseph H.
Messinger, Yoav
Liang, Wei
Hume, Robin
Hannah, Alison L.
Soiffer, Robert J.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S92 - S93
[6] Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation or Chemotherapy-Results from the Italian Therapeutic Use Protocol
Locatelli, Franco
Faraci, Maura
Cesaro, Simone
Pagliara, Daria
Fagioli, Franca
Zecca, Marco
Amber, Vian
Banerjee, Kamalika
Finetto, Giorgia
Ciceri, Fabio
BLOOD, 2015, 126 (23)
[7] Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation
Kumar, S
DeLeve, LD
Kamath, PS
Tefferi, A
MAYO CLINIC PROCEEDINGS, 2003, 78 (05) : 589 - 598
[8] Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
Mohty, Mohamad
Blaise, Didier
De Latour, Regis Peffault
Labopin, Myriam
Detrait, Marie
Girault, Stephane
Huynh, Anne
Labussiere-Wallet, Helene
Lamy, Thierry
Lebon, Delphine
Maury, Sebastien
Renard, Cecile
Asubonteng, Kobby
Delaval, Floriane
Yakoub-Agha, Ibrahim
Dalle, Jean-Hugues
BLOOD, 2021, 138 : 1789 - +
[9] Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome
Richardson, Paul G.
Triplett, Brandon M.
Ho, Vincent T.
Chao, Nelson
Dignan, Fiona L.
Maglio, Michelle
Mohty, Mohamad
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (02) : 113 - 124
[10] The defifrance registry study: Effectiveness and safety of defibrotide in patients with veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) following chemotherapy
Yakoub-Agha, I.
Blaise, D.
Dalle, J. -H.
Labopin, M.
De latour, R. Peffault
Chantepie, S.
Petit, A.
Asubonteng, K.
Duchene, F.
Mohty, M.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 339 - 340

← 1 2 3 4 5 →